Join the Nasopharyngeal Carcinoma group to help and get support from people like you.
Nasopharyngeal Carcinoma News
Related terms: Nasopharyngeal Cancer, NPC, Lymphoepithelioma
Monthly News Roundup - October 2023
FDA Clears Loqtorzi as First Treatment for Nasopharyngeal Carcinoma (NPC) In October, the U.S. Food and Drug Administration (FDA) approved Coherus BioSciences’ Loqtorzi (toripalimab-tpzi) to treat a...
FDA Approves Loqtorzi (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
REDWOOD CITY, Calif. and SHANGHAI, China, Oct. 27, 2023 (GLOBE NEWSWIRE) – Coherus BioSciences, Inc. (“Coherus”, NASDAQ: CHRS), and Shanghai Junshi Biosciences Co., Ltd. (Junshi Biosciences, HKEX: 18...
Threshold of 6 mm on Retropharyngeal Lymph Node Predicts PFS in Nasopharyngeal Carcinoma
MONDAY, Oct. 2, 2023 – For patients with nasopharyngeal carcinoma (NPC), a minimal axial diameter (MAD) threshold of 6 mm for retropharyngeal lymph node (RLN) predicts survival, according to a study...
Ask a question
To post your own question to this support group, sign in or create an account.